NCT00437554View on ClinicalTrials.gov

Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)

PHASE3CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

July 31, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Glimepiride

Trial Locations (1)

Unknown

Handok, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT00437554 - Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR) | Biotech Hunter | Biotech Hunter